Pathstone Family Office’s Alnylam Pharmaceuticals ALNY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | $220K | Buy |
+1,240
| New | +$220K | ﹤0.01% | 1451 |
|
|
2014
Q4 | – | Sell |
-17
| Closed | -$1K | – | 115 |
|
|
2014
Q3 | $1K | Buy |
+17
| New | +$1K | ﹤0.01% | 299 |
|
|
2014
Q2 | – | Sell |
-17
| Closed | -$1K | – | 135 |
|
|
2014
Q1 | $1K | Buy |
+17
| New | +$1K | ﹤0.01% | 166 |
|
|
2013
Q4 | – | Sell |
-417
| Closed | -$27K | – | 197 |
|
|
2013
Q3 | $27K | Buy |
+417
| New | +$27K | 0.12% | 115 |
|